一个破坏性的可点击抗体设计,用于生成抗体与药物合物的抗体
Nathanaël Rakotoarinoro1,2, Yan F K Dyck2, Simon K Krebs1,3
1Institute for Cell Therapy and Immunology branch Bioanalytics and Bioprocesses, Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 14476 Potsdam-Golm, Germany.
Antibody therapeutics
|December 18, 2023
概括
这项研究引入了一种新的抗体-药物合物 (ADC) 方法,通过将细胞毒药物合到埋藏的抗体部位. 这种方法提高了ADC的水友性和稳定性,改善了癌症治疗方法.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 抗体-药物合物 (ADC) 是一种向癌症治疗药物,它将抗体特异性与药物毒性相结合.
- 目前的ADC策略将药物与暴露在表面的抗体区域结合,往往导致水性增加,肝脏清除,并且由于药物链接特性而降低稳定性.
- 优化ADC设计对于提高治疗疗效和安全性非常重要.
研究的目的:
- 开发一种新的抗体-药物联合体 (ADC) 设计策略,以提高水友性和稳定性.
- 通过准埋藏的抗体部位,探索一种非传统的药物结合方法.
- 为了保持结合效率和治疗功能,同时减轻与疏水性相关的问题.
主要方法:
- 设计了一种"准备点击"的抗体设计,在Fab腔内使用无意义抑制技术结合一种基于阿齐多的非正规氨基酸.
- 将药物链接器结合部位引入抗体的埋藏区域,特别是Fab腔,以避免Fc相关的裂解问题.
- 研究了这种埋藏的结合策略对ADC水友性,稳定性和功能性的影响.
主要成果:
- 新型抗体设计显著提高了由此产生的抗体-药物合物的水友性,与现有的非正规氨基酸基ADC相比.
- 成功地保持了ADC的结合效率和整体功能.
- 该研究表明了"本地屏蔽"效应的强度和拟议的结合方法的多功能性.
结论:
- 这种先进的抗体-药物结合体设计提供了一种新的策略,通过增强水友性和稳定性来改善ADC的特性.
- 该方法提供了一种潜在的方法来保护药物和链接剂免受非特异性相互作用的影响,减少非目标效应.
- 这种设计代表了一项重大进步,也是未来癌症治疗中ADC开发的有价值选择.
更多相关视频
09:06Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
Published on: December 23, 2016
21.0K
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
7.8K
相关概念视频
01:10Antibody Structure
60.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.2K
01:26Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
01:25Antibody Structure and Classes
919
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
919